Trial intelligence / Profile preview

CellCept Fixed Dose vs. Concentration Controlled in Kidney Transplant

NCT00217152Phase 4Terminated

Sponsor
Mayo Clinic
Start
Mar 2005
Primary completion
Aug 2007
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in kidney transplantation, sponsored by Mayo Clinic. Started Mar 2005; status: terminated.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT00217152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00217152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call